Asta Försti researcher
Försti, Asta
VIAF ID: 1997152261521717180007 (Personal)
Permalink: http://viaf.org/viaf/1997152261521717180007
Preferred Forms
-
100 0 _
‡a
Asta Försti
‡c
researcher
-
100 1 _
‡a
Försti, Asta
4xx's: Alternate Name Forms (1)
5xx's: Related Names (2)
- 510 2 _
‡a
Deutsches Krebsforschungszentrum
‡b
Abteilung Molekulargenetische Epidemiologie
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 510 2 _
‡a
Universität Heidelberg
‡b
Medizinische Fakultät
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
Works
| Title | Sources |
|---|---|
| Cancer predisposition genes in cancer-free families |
|
| Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma |
|
| Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts. |
|
| A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3) |
|
| Germline genetics of cancer of unknown primary (CUP) and its specific subtypes |
|
| A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer |
|
| Germline variants of CYBA and TRPM4 predispose to familial colorectal cancer |
|
| High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk |
|
| Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
|
| Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
|
| Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population |
|
| Incidence and familial risks in pituitary adenoma and associated tumors |
|
| Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues |
|
| Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases |
|
| The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications |
|
| Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease |
|
| Inherited genetic susceptibility to monoclonal gammopathy of unknown significance |
|
| Inherited variants in genes somatically mutated in thyroid cancer |
|
| The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer. |
|
| Investigation of rare non-coding variants in familial multiple myeloma |
|
| Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer |
|
| A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
|
| Levels of DNA damage (Micronuclei) in patients suffering from chronic kidney disease. Role of GST polymorphisms |
|
| Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients |
|
| Metabolic gene variants associated with chromosomal aberrations in healthy humans |
|
| Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort |
|
| Multiple myeloma: family history and mortality in second primary cancers |
|
| New cancer susceptibility loci: population and familial risks |
|
| Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk |
|
| Origin of B-Cell Neoplasms in Autoimmune Disease |
|
| Pedigree based DNA sequencing pipeline for germline genomes of cancer families |
|
| Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
|
| Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers |
|
| Polymorphisms in CTNNBL1 in relation to colorectal cancer with evolutionary implications |
|
| Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer |
|
| Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer |
|
| Prediction of breast cancer risk based on profiling with common genetic variants |
|
| Preventable breast cancer is postmenopausal |
|
| Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression |
|
| Proper controls for SNP studies? |
|
| Re: Integrin beta3 Leu33Pro homozygosity and risk of cancer |
|
| Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis |
|
| Re: "underlying genetic models of inheritance in established type 2 diabetes associations". |
|
| Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer |
|
| Recurrent Germline Variant in <i>RAD21</i> Predisposes Children to Lymphoblastic Leukemia or Lymphoma |
|
| Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer |
|
| Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study |
|
| Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis |
|
| Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas |
|
| Runs of homozygosity and inbreeding in thyroid cancer |
|
| Searching for the missing heritability of complex diseases |
|
| Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. |
|
| Shared ancestral susceptibility to colorectal cancer and other nutrition related diseases |
|
| The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer. |
|
| Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study |
|
| Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events |
|
| Subsequent brain tumors in patients with autoimmune disease |
|
| Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis |
|
| Survival in familial and non-familial breast cancer by age and stage at diagnosis |
|
| Survival in ovarian cancer patients by histology and family history |
|
| Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development |
|
| Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome |
|
| Thalassemia and sickle cell anemia in Swedish immigrants: Genetic diseases have become global |
|
| Thyroid-associated genetic polymorphisms in relation to breast cancer risk in the Malmö Diet and Cancer Study |
|
| Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma |
|
| Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis |
|
| Whole-exome sequencing identifies a novel germline variant in PTK7 gene in familial colorectal cancer |
|
| Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma [Letter] |
|
